ARS Pharmaceuticals Inc (SPRY)
9.06
+0.19
(+2.14%)
USD |
NASDAQ |
Jun 03, 16:00
9.06
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Market Cap: 877.87M for June 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 859.46M |
| May 30, 2024 | 863.34M |
| May 29, 2024 | 854.62M |
| May 28, 2024 | 870.12M |
| May 24, 2024 | 870.12M |
| May 23, 2024 | 852.68M |
| May 22, 2024 | 865.28M |
| May 21, 2024 | 855.59M |
| May 20, 2024 | 890.47M |
| May 17, 2024 | 874.96M |
| May 16, 2024 | 881.75M |
| May 15, 2024 | 860.43M |
| May 14, 2024 | 870.12M |
| May 13, 2024 | 861.40M |
| May 10, 2024 | 846.86M |
| May 09, 2024 | 852.68M |
| May 08, 2024 | 877.87M |
| May 07, 2024 | 917.60M |
| May 06, 2024 | 915.66M |
| May 03, 2024 | 944.72M |
| May 02, 2024 | 916.62M |
| May 01, 2024 | 904.02M |
| April 30, 2024 | 842.98M |
| April 29, 2024 | 833.29M |
| April 26, 2024 | 809.07M |
| Date | Value |
|---|---|
| April 25, 2024 | 783.88M |
| April 24, 2024 | 800.35M |
| April 23, 2024 | 820.88M |
| April 22, 2024 | 792.87M |
| April 19, 2024 | 817.98M |
| April 18, 2024 | 815.08M |
| April 17, 2024 | 874.96M |
| April 16, 2024 | 886.55M |
| April 15, 2024 | 892.34M |
| April 12, 2024 | 871.10M |
| April 11, 2024 | 892.34M |
| April 10, 2024 | 895.24M |
| April 09, 2024 | 901.04M |
| April 08, 2024 | 958.98M |
| April 05, 2024 | 953.19M |
| April 04, 2024 | 920.35M |
| April 03, 2024 | 907.80M |
| April 02, 2024 | 896.21M |
| April 01, 2024 | 914.56M |
| March 28, 2024 | 986.25M |
| March 27, 2024 | 961.16M |
| March 26, 2024 | 965.02M |
| March 25, 2024 | 881.06M |
| March 22, 2024 | 834.74M |
| March 21, 2024 | 868.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
279.06M
Minimum
Sep 20 2023
986.25M
Maximum
Mar 28 2024
655.24M
Average
658.10M
Median
Market Cap Benchmarks
| KalVista Pharmaceuticals Inc | 509.21M |
| Phathom Pharmaceuticals Inc | 601.16M |
| Vera Therapeutics Inc | 2.206B |
| Nuvalent Inc | 4.452B |
| CEL-SCI Corp | 64.99M |
Market Cap Related Metrics
| Price to Book Value | 3.921 |
| Price | 9.06 |
| Earnings Yield | -5.74% |